Advertisement

With Coronavirus Vaccines on The Way, Researchers Say It’s Time to

iam platform login page background

BEGIN ARTICLE PREVIEW:

At least three coronavirus vaccines are on the horizon, but some Americans appear hesitant to be first in line to take them.As the likely distribution of COVID-19 vaccines draws near, researchers say it’s time to begin educating Americans about medical research and the vaccine, with a focus on building trust — particularly in communities that experience higher levels of distrust. Thanks to our sponsors:
A September survey conducted by the Pew Research Center found that just 51% of U.S. adults said they would “definitely or probably” get a COVID-19 vaccine if it were available the day they took the survey. 
“What makes people hesitant? They’re not sure it will work. Sometimes it’s about side effects. They want to know that it is indeed going to protect them, and that’s a message that we need to make sure we get out there,” said Kenzie Cameron, a research professor in general internal medicine and geriatrics at Northwestern Medicine. Cameron is a health services researcher with a background that includes health communication, and has studied racial and ethnic disparities in the flu vaccine.  
Vaccine skepticism is highest among Black Americans — a community that sees historic mistrust in the American medical …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE

Former Berlin airport gets new life as vaccination centre

iam platform login page background

BEGIN ARTICLE PREVIEW:

A large “Welcome” sign still hangs outside Berlin’s Tegel airport, which closed for good in November.But thousands of people are soon expected to start walking through its doors again every day, once its Terminal C building has been refitted as a vaccination centre against the novel coronavirus from mid-December.Germany is hoping to ramp up its immunisation drive in the first quarter of 2021 and is already laying the groundwork for 60 hubs across the country.While Health Minister Jens Spahn insists that vaccination will not be compulsory, Chancellor Angela Merkel told parliament on Thursday that vaccines represented “a light at the end of the tunnel” for Germany.The country has seen case numbers stabilise since leisure and sporting facilities and indoors dining were closed in early November, but the caseload remains high, with 22,268 new infections and 389 deaths reported on Thursday.The winter will be tough, but “I believe that we will see significant progress next year,” Merkel said, describing vaccines as a sign of “hope”.- 20,000 jabs a day -The federal government will be responsible for the purchase and delivery of the jabs, while the regional states will provide equipment and choose the locations for the vaccination centres.At Tegel, ” …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Former Berlin airport gets new life as vaccination centre”

Moscow awaits large supplies of COVID-19 vaccine for mass vaccination – Metro US

iam platform login page background

BEGIN ARTICLE PREVIEW:

FILE PHOTO: Bottles with Russia’s “Sputnik-V” vaccine against the coronavirus disease (COVID-19) are seen before inoculation at a clinic in Tver


Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York CityMOSCOW (Reuters) – Moscow is ready for a mass vaccination against COVID-19 and is currently awaiting large supplies of vaccine, its Mayor Sergei Sobyanin said on Thursday.
Sobyanin said there were no plans to put Moscow under lockdown even though Russia has been reporting record high numbers of new coronavirus infections and deaths in the past few weeks.
Russia says its Sputnik V vaccine is 92% effective at protecting people from COVID-19, as Moscow rushes to keep pace with Western drugmakers in the race for an effective vaccine.

(Reporting by Vladimir Soldatkin; Writing by Andrey Ostroukh; Editing by Jon Boyle)

About the Author

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Moscow awaits large supplies of COVID-19 vaccine for mass vaccination – Metro US”

Scrutiny grows over Oxford University/AstraZeneca vaccine

iam platform login page background

BEGIN ARTICLE PREVIEW:

The Oxford University/AstraZeneca vaccine will undergo a new global trial as critics questioned the claim that it could protect up to 90% of people against coronavirus.On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences adviser, dismissed suggestions the previous trial had not been properly set up or reported. “We weren’t cooking this up as we went along,” he said, adding that he hoped the full, peer-reviewed data would be published in the Lancet medical journal at the weekend.In spite of the public excitement generated by the announcement that a third vaccine had been successful – with particular promise for developing countries as it is relatively cheap and can be stored at fridge temperature – AstraZeneca’s share price dropped.One analyst in the US wrote in an investor note that “we believe that this product will never be licensed in the US” and alleged the company had tried to “embellish” the results.However the UK government has asked the Medicines and Healthcare products Regulatory Agency (MHRA), the body which licences vaccines in Britain, to start the approval process for the jab. The health secretary, Matt Hancock, who has ordered 100m …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Scrutiny grows over Oxford University/AstraZeneca vaccine”

Biopharma industry works to build confidence in Covid-19 vaccines – STAT

iam platform login page background

BEGIN ARTICLE PREVIEW:

Over the last few weeks, the United States has surpassed 100,000 Covid-19 cases a day and reached the staggering milestone of 10 million cases. This is both sobering and humbling.
While there has been encouraging news about progress in the development of Covid-19 vaccines, making sure that Americans have confidence in these vaccines is crucial to helping bend the curve of infections and getting us back to some semblance of normalcy.
According to researchers writing in The Lancet, we will need a majority of Americans to have the confidence to get vaccinated for Covid-19 vaccines to be effective in moving the U.S. toward population-level control of viral spread. As Anthony Fauci has noted, “If you have a vaccine that is highly effective and not enough people get vaccinated, you’re not going to realize the full, important effect of having a vaccine.”
advertisement

Widely reported public opinion polls have suggested that a sizable portion of the public is in a wait-and-see mode for getting vaccinated against Covid-19. My colleagues and I in the biopharmaceutical industry, an industry built on science, recognize that one of our duties in the Covid-19 pandemic is to lift the veil on the processes that companies are …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Biopharma industry works to build confidence in Covid-19 vaccines – STAT”

Canada can start importing COVID-19 vaccines before approved for use: feds

iam platform login page background

BEGIN ARTICLE PREVIEW:

OTTAWA (NEWS 1130) – Nurses, doctors, police officers, and firefighters will be among those first in line to get a COVID-19 vaccine.
Deputy Public Health Officer Dr. Howard Njoo outlined the country’s vaccine rollout on Thursday, confirming Canada is expecting six-million doses of vaccines in the first quarter of 2021.
“We’re doing everything we can to give Canadians access to the safest, most effective COVID-19 vaccines in the world,” Njoo said at the first in a series of weekly briefings on Canada’s vaccination efforts.

Dr. Njoo confirms they expect 6-million doses of COVID-19 vaccines in the first quarter of 2021. However since people will need 2 doses, that means 3-million Canadians should be inoculated in the early months of next year. #cdnpoli
— Cormac Mac Sweeney (@cmaconthehill) November 26, 2020

The vulnerable will also be among those to get a COVID-19 vaccine first, alongside those working on the frontline, he added.
Under emergency orders, Dr. Supriya Sharma, chief medical advisor to the deputy minister at Health Canada, said the country can start receiving and storing doses before Health Canada has even approved a vaccine for use here
“Those vaccines would only be distributed and they would go through vaccination after Health Canada has authorized it,” …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Canada can start importing COVID-19 vaccines before approved for use: feds”

India coronavirus: How do you vaccinate a billion people?

iam platform login page background

BEGIN ARTICLE PREVIEW:

*:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}]]> Soutik BiswasIndia correspondent *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-left:0.5rem;}]]> image copyrightReuters *:not([hidden]):not(style) ~ *:not([hidden]):not(style){margin-top:1rem;}]]>When it comes to vaccine making, India is a powerhouse. It runs a massive immunisation programme, makes 60% of the world’s vaccines and is home to half a dozen major manufacturers, including Serum Institute of India – the largest in the world. Not surprisingly, there’s no lack of ambition when it comes to vaccinating a billion people against Covid-19. India plans to receive and utilise some 500 million doses of vaccines against the disease and immunise up to 250 million people by July next year. This confidence is bolstered by its track record of immunising large numbers of people every year. India’s 42-year-old immunisation programme, one of the world’s largest health programmes, targets 55 million people – mainly newborns and pregnant women who receive some 390 million free doses of vaccines against a dozen diseases every year. The country also has a well-oiled electronic system to stock and track these vaccines. Yet vaccinating a billion people, including hundreds of millions of adults for the first time, against Covid-19 is going …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “India coronavirus: How do you vaccinate a billion people?”

Widespread COVID-19 vaccination in Africa will likely start mid-2021

iam platform login page background

BEGIN ARTICLE PREVIEW:

A medic fills a syringe with an experimental COVID-19 vaccine. Photo by: Amit Dave / ReutersNAIROBI — Widespread campaigns to distribute COVID-19 vaccines in Africa will likely only begin in the second quarter of next year because of challenges around accessing vaccines and preparing countries for their distribution, said John Nkengasong, Africa Centres for Disease Control and Prevention director, during a press conference Thursday.“It will not be, in my view, up until the middle of next year before we start truly getting vaccinations into Africa,” he said.Positive interim results from three candidate vaccines have bolstered global confidence that there is an end in sight to the pandemic. But not all of these vaccines are appropriate for a roll out in the African context.“The largest immunization drive in Africa’s history is right around the corner, and African governments must urgently ramp up readiness.”— Dr. Matshidiso Moeti, regional director for Africa, World Health OrganizationThe cold temperatures required for the storage and distribution of the Pfizer-BioNTech and Moderna vaccines would make them a challenge to distribute in Africa quickly, Nkengasong said. While the Oxford-AstraZeneca vaccine had lower interim efficacy results, it does offer the best possibility for distribution on the continent …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Widespread COVID-19 vaccination in Africa will likely start mid-2021”

Russia’s Sputnik V developers call on AstraZeneca to try combining vaccines

iam platform login page background

BEGIN ARTICLE PREVIEW:

By Reuters Staff2 Min ReadMOSCOW (Reuters) – Developers of the Sputnik V COVID-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.FILE PHOTO: A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado RuvicRussia said its Sputnik V vaccine is 92% effective at protecting people from COVID-19, according to interim trial results, while AstraZeneca said its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective.“If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy,” the developers of the Russian vaccine said on their Twitter account.“Combining vaccines may prove important for revaccinations.”AstraZeneca has said it will have as many as 200 million doses of its vaccine by the end of 2020.The British developed vaccine is viewed as offering one of the best hopes for many developing countries because of its cheaper price and ability to be transported at normal fridge temperatures.With 2,187,990 infections, Russia has the fourth-largest number of COVID-19 cases in the …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Russia’s Sputnik V developers call on AstraZeneca to try combining vaccines”

Indiana health official: States told COVID-19 vaccines will be sent within 48 hours after approval

iam platform login page background

BEGIN ARTICLE PREVIEW:

It will not take much time for states to begin receiving COVID-19 vaccines when they get the green light from the Food and Drug Administration.That new bit of information was provided Wednesday by Dr. Kristina Box, commissioner for the Indiana Department of Health. She said states have been told to prepare to receive vaccines within 48 hours when the first emergency use authorization is issued by the FDA.Box gave a roundup of the latest details her office has learned with the race to release a COVID-19 vaccine kicking into high gear after a couple weeks of good news from manufacturers.According to Box, Pfizer — one of the companies developing a vaccine — has already applied for emergency use authorization. That comes after the company announced that its vaccine appears to be 95% effective at preventing mild to severe COVID-19 disease.Box said the FDA has schedule a meeting in early December on whether to issue the authorization. She said if it’s approved, vaccines will quickly go into distribution.Indiana’s top health official said the state is communicating with hospitals and front-line health workers to prepare staff to receive vaccines. The state previously released its vaccine distribution plan, but the first phase …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Indiana health official: States told COVID-19 vaccines will be sent within 48 hours after approval”